{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "2017", "item": "https://www.patentleaderboard.com/2017/"}, {"@type": "ListItem", "position": 3, "name": "Pfizer", "item": "https://www.patentleaderboard.com/2017/company/pfizer"}, {"@type": "ListItem", "position": 4, "name": "Benjamin Thuma", "item": "https://www.patentleaderboard.com/2017/inventor/fl:be_ln:thuma-1"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
BT

Benjamin Thuma — 2 Patents in 2017

Pfizer: 2 patents #50 of 344Top 15%
Old Lyme, CT: #4 of 18 inventorsTop 25%
Connecticut: #645 of 3,711 inventorsTop 20%
Overall (2017): #168,003 of 506,227Top 35%
2 Patents 2017

Issued Patents 2017

Showing 1–2 of 2 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
9809579 Substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitors Matthew S. Dowling, Dilinie Fernando, Kentaro Futatsugi, Kim Huard, Thomas Victor Magee +5 more 2017-11-07 $741,555,000
9617293 Substituted-6,8-dioxabicyclo[3.2.1]octane-2,3-diol compounds as targeting agents of ASGPR Spiros Liras, Vincent Mascitti 2017-04-11 $241,476,000